Association of Disease Activity with Serum and Tear IL-2 Levels in Behc, et Disease

dc.contributor.authorTurkcuoglu, Peykan
dc.contributor.authorArat, Yonca Ozkan
dc.contributor.authorKan, Emrah
dc.contributor.authorKan, Elif Kilic
dc.contributor.authorChaudhry, Imtiaz A.
dc.contributor.authorKoca, Suleyman
dc.contributor.authorIlhan, Nevin
dc.date.accessioned2026-08-12T17:32:35Z
dc.date.issued2016
dc.departmentFırat Üniversitesi
dc.description.abstractPurpose: To investigate the association of Behcet disease activity with serum and tear interleukin-2 levels. Methods: The study was designed as a prospective case control study. The study population consisted of 45 patients with Behcet disease and 24 age and sex-matched healthy participants. Behcet disease patients were classified as active (24 patients) or inactive (21 patients) according to disease activity. Serum and tear interleukin-2 levels were determined using the enzyme-linked immunosorbent assay method. Results: The mean serum and tear interleukin-2 levels of the active disease, inactive disease, and control groups were 17.04 +/- 5.02 and 32.61 +/- 16.53 pg/mL; 15.20 +/- 4.68 and 29.61 +/- 8.30 pg/mL; and 14.22 +/- 4.18 and 28.89 +/- 8.73 pg/mL, respectively. There was no statistically significant difference between the groups with respect to all measured data. Conclusions: There was no significant difference in serum or tear IL-2 levels between Behcet patients and controls; there was no association of disease activity with serum and tear IL-2 levels.
dc.identifier.doi10.3109/09273948.2014.1003661
dc.identifier.endpage318
dc.identifier.issn0927-3948
dc.identifier.issn1744-5078
dc.identifier.issue3
dc.identifier.orcid0000-0003-4995-430X
dc.identifier.orcid0000-0002-9750-6213
dc.identifier.orcid0000-0002-6578-7444
dc.identifier.orcid0000-0002-0208-8929
dc.identifier.orcid0000-0001-5056-4689
dc.identifier.pmid26110544
dc.identifier.scopus2-s2.0-84939525492
dc.identifier.scopusqualityQ1
dc.identifier.startpage313
dc.identifier.urihttps://doi.org/10.3109/09273948.2014.1003661
dc.identifier.urihttps://hdl.handle.net/11508/56699
dc.identifier.volume24
dc.identifier.wosWOS:000377981500012
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Inc
dc.relation.ispartofOcular Immunology and Inflammation
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectBehcet
dc.subjectBehcet's disease
dc.subjectinterleukin
dc.subjectinterleukin-2
dc.subjecttear interleukin
dc.titleAssociation of Disease Activity with Serum and Tear IL-2 Levels in Behc, et Disease
dc.typeArticle

Dosyalar